Global Circulating Tumor Cells Market Report By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods And CTC Analysis), By Application (Multiple chromosome abnormalities, RNA profiling, Protein expression, Cellular communication And Others), By End-Use (Research & academic institutes, Hospital & clinics And Diagnostic centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212629
June 2020
Report Formats:

The global demand for Circulating Tumor Cells Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
A circulating tumor cell (CTC) is a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation. CTCs can extravasate and become seeds for the subsequent growth of additional tumors (metastases) in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths. The detection and analysis of CTCs can assist early patient prognoses and determine appropriate tailored treatments. Currently, there is one FDA-approved method for CTC detection, CellSearch, which is used to diagnose breast, colorectal and prostate cancer.
 
Market Dynamics
 
High growth in attributed to rising prevalence of cancer globally. As per research, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer, fuelling the market growth. Furthermore, technological advancement in biomedical imaging and bioengineering processes will further augment market growth. On the flip side, lack of awareness among the population hamper the market growth.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of circulating tumor cells.
 
Market Segmentation
 
The entire circulating tumor cells market has been sub-categorized into technology, application, and end-use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Technology

  • CTC Detection & Enrichment Methods
  • CTC Direct Detection Methods
  • CTC Analysis
 
By Application
  • Multiple Chromosome Abnormalities
  • RNA Profiling
  • Protein Expression
  • Cellular Communication
  • Others
 
By End-Use
  • Research & Academic Institutes
  • Hospital & Clinics
  • Diagnostic Centers
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for circulating tumor cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Circulating Tumor Cells Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the circulating tumor cells market include Aviva Biosciences, Advanced Cell Diagnostics Inc., Biocept Inc., LungLife AI Inc., Creatv Micro Tech, Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Precision for Medicine and Qiagen NV. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Circulating Tumor Cells Market
       2.2. Global Circulating Tumor Cells Market Snapshot
 
3 . CIRCULATING TUMOR CELLS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Circulating Tumor Cells Market
       3.3. Market Restraints of Circulating Tumor Cells Market
       3.4. Opportunities of Circulating Tumor Cells Market
       3.5. Trends of Circulating Tumor Cells Market
       3.6. Porter’s Five Force Analysis of Circulating Tumor Cells Market
       3.7. Circulating Tumor Cells Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by End-Use
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Circulating Tumor Cells Value Chain Analysis
       4.2. Circulating Tumor Cells Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Circulating Tumor Cells Raw Material Manufactures List
           4.2.3. Price Trend of Circulating Tumor Cells Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Circulating Tumor Cells Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Circulating Tumor Cells Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Circulating Tumor Cells Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Circulating Tumor Cells Market
 
6 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY TECHNOLOGY
       6.1 Overview by Technology
       6.2 Global Circulating Tumor Cells Market Analysis by Technology
       6.3 Market Analysis of CTC Detection & Enrichment Methods by Regions
       6.4 Market Analysis of CTC Direct Detection Methods by Regions
       6.6 Market Analysis of CTC Analysis by Regions
 
7 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Circulating Tumor Cells Market Analysis by Application
       7.3 Market Analysis of Multiple Chromosome Abnormalities by Regions
       7.4 Market Analysis of RNA Profiling by Regions
       7.5 Market Analysis of Protein Expression by Regions
       7.6 Market Analysis of Cellular Communication by Regions
       7.7 Market Analysis of Others by Regions
 
8 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY END-USE
       8.1 Overview by End-Use
       8.2 Global Circulating Tumor Cells Market Analysis by End-Use
       8.3 Market Analysis of Research & Academic Institutes by Regions
       8.4 Market Analysis of Hospital & Clinics by Regions
       8.5 Market Analysis of Diagnostic Centers by Regions
 
9 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Circulating Tumor Cells Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Circulating Tumor Cells Market Estimate by Market Segment
           9.4.3. Europe Circulating Tumor Cells Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Circulating Tumor Cells Market Estimate by Market Segment
           9.5.3. Asia Pacific Circulating Tumor Cells Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Circulating Tumor Cells Market Estimate by Market Segment
           9.6.3. Latin America Circulating Tumor Cells Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Circulating Tumor Cells Market Estimate by Market Segment
           9.7.3. Middle East & Africa Circulating Tumor Cells Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE CIRCULATING TUMOR CELLS COMPANIES
       10.1. Circulating Tumor Cells Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF CIRCULATING TUMOR CELLS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Aviva Biosciences
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Advanced Cell Diagnostics Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Biocept Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. LungLife AI Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Creatv Micro Tech, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Miltenyi Biotec
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Menarini Silicon Biosystems
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Precision for Medicine
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Qiagen NV
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Circulating Tumor Cells Market Snapshot
  • Drivers of The Global Circulating Tumor Cells Market Impact Analysis
  • Restraints of The Global Circulating Tumor Cells Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Circulating Tumor Cells Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Circulating Tumor Cells Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Circulating Tumor Cells Market
  • Global Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Detection & Enrichment Methods by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Direct Detection Methods by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Analysis by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis by Application (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Multiple Chromosome Abnormalities by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in RNA Profiling by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Protein Expression by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Cellular Communication by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Others by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis by End-Use (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Research & Academic Institutes by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Hospital & Clinics by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Diagnostic Centers by Geography (USD MN)
  • Global Circulating Tumor Cells Market by Geography (USD MN)
  • North America Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • North America Circulating Tumor Cells Market Estimate by Application (USD MN)
  • North America Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • North America Circulating Tumor Cells Market Estimate by Country (USD MN)
  • United State Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • United State Circulating Tumor Cells Market Estimate by Application (USD MN)
  • United State Circulating Tumor Cells Market Analysis by End-Use (USD MN)
  • Rest of North America Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Rest of North America Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Rest of North America Circulating Tumor Cells Market Estimate by End-Use(USD MN)
  • Europe Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Europe Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Europe Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • United Kingdom Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • United Kingdom Circulating Tumor Cells Market Estimate by Application (USD MN)
  • United Kingdom Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • France Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • France Circulating Tumor Cells Market Estimate by Application (USD MN)
  • France Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Germany Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Germany Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Germany Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Rest of Europe Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Rest of Europe Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Rest of Europe Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Asia Pacific Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Asia Pacific Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Asia Pacific Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Asia Pacific Circulating Tumor Cells Market Estimate by Country (USD MN)
  • China Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • China Circulating Tumor Cells Market Estimate by Application (USD MN)
  • China Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Japan Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Japan Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Japan Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • India Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • India Circulating Tumor Cells Market Estimate by Application (USD MN)
  • India Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Rest of Asia Pacific Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Rest of Asia Pacific Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Latin America Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Latin America Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Latin America Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Latin America Circulating Tumor Cells Market Estimate by Country (USD MN)
  • Brazil Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Brazil Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Brazil Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Rest of Latin America Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Rest of Latin America Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Rest of Latin America Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Middle East & Africa Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Middle East & Africa Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Middle East & Africa Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Middle East & Africa Circulating Tumor Cells Market Estimate by Country (USD MN)
  • Middle East Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Middle East Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Middle East Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Africa Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Africa Circulating Tumor Cells Market Estimate by Application (USD MN)
  • Africa Circulating Tumor Cells Market Estimate by End-Use (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Circulating Tumor Cells Report
  • Market Research Process
  • Market Research Methodology
  • Global Circulating Tumor Cells Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Circulating Tumor Cells Market Analysis by Technology (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Detection & Enrichment Methods by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Direct Detection Methods by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in CTC Analysis by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis by Application (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Multiple Chromosome Abnormalities by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in RNA Profiling by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Protein Expression by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Cellular Communication by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Others by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis by End-Use (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Research & Academic Institutes by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Hospital & Clinics by Geography (USD MN)
  • Global Circulating Tumor Cells Market Analysis in Diagnostic Centers by Geography (USD MN)
  • Latin America Circulating Tumor Cells Market by Revenue
  • Middle East & Africa Circulating Tumor Cells Market by Revenue
  • Recent Development in Circulating Tumor Cells Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials